Growth Metrics

SBC Medical Group Holdings (SBC) Return on Sales (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Return on Sales for 3 consecutive years, with 0.3% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 24.0% year-over-year to 0.3%, compared with a TTM value of 0.25% through Sep 2025, down 10.0%, and an annual FY2024 reading of 0.23%, up 1.0% over the prior year.
  • Return on Sales was 0.3% for Q3 2025 at SBC Medical Group Holdings, up from 0.06% in the prior quarter.
  • Across five years, Return on Sales topped out at 44.01% in Q4 2023 and bottomed at 0.05% in Q3 2024.
  • Average Return on Sales over 3 years is 5.19%, with a median of 0.3% recorded in 2025.
  • The sharpest move saw Return on Sales plummeted -4382bps in 2024, then increased 24bps in 2025.
  • Year by year, Return on Sales stood at 44.01% in 2023, then tumbled by -100bps to 0.2% in 2024, then soared by 51bps to 0.3% in 2025.
  • Business Quant data shows Return on Sales for SBC at 0.3% in Q3 2025, 0.06% in Q2 2025, and 0.45% in Q1 2025.